Company Filing History:
Years Active: 2025
Title: Hirotake Komatsu: Innovator in Cell Transplantation Technology
Introduction
Hirotake Komatsu is a notable inventor based in Temple City, California. He has made significant contributions to the field of biomedical engineering, particularly in the area of cell transplantation. His innovative work has led to the development of a unique patent that addresses critical challenges in therapeutic cell implants.
Latest Patents
Hirotake Komatsu holds a patent for a "Microcapillary mesh oxygen transporter for cell transplantations." This invention features a two-dimensional lattice or mesh scaffold designed for therapeutic cell implants. The lattice is constructed from crisscrossing capillaries made of hydrophobic parylene, specifically parylene AF4, which can be coated with a hydrophilic polymer like parylene C to enhance cell adhesion. The design allows for free oxygen flow within the mesh, as the walls of the capillaries are thin enough to be permeable to oxygen. This innovative approach enables cells to be sandwiched between lattices, preventing aggregation and promoting effective implantation within a subject.
Career Highlights
Throughout his career, Hirotake Komatsu has worked with prestigious institutions, including the California Institute of Technology and City of Hope. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cell transplantation technologies.
Collaborations
Hirotake Komatsu has collaborated with notable colleagues such as Yu-Chong Tai and Kuang-Ming Shang. These partnerships have further enriched his research and development efforts, leading to advancements in the biomedical field.
Conclusion
Hirotake Komatsu's innovative contributions to cell transplantation technology exemplify the impact of dedicated inventors in the biomedical field. His patent for the microcapillary mesh oxygen transporter showcases his commitment to improving therapeutic outcomes for patients.